• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

XUP:GR

21.430 EUR 0.860 3.86%

As of 02:14:13 ET on 04/17/2014.

Snapshot for Genfit (XUP)

Open: 21.470 Day's Range: 21.430 - 21.470 Volume: 0
Previous Close: 22.290 52wk Range: 4.041 - 32.080 1-Yr Rtn: +220.79%

Stock Chart for XUP

No chart data available.
  • XUP:GR 21.470
  • 1D
  • 1M
  • 1Y
22.290
Interactive XUP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XUP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 455.55
Shares Outstanding (M) 21.26
30 Day Average Volume 28
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XUP

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for XUP

Genfit is a biopharmaceutical company. The Company researches treatments for cardiovascular, metabolic and inflammatory diseases, and age-linked neurodegenerative disorders.

Jean-Francois MouneyChairman-Mgmt Board/Co-FounderNathalie HuitorelMember-Mgmt Board
Raphael DarteilMember-Mgmt Board
More Company Profile & Key Executives for XUP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil